Budesonide/Formoterol Added to Tiotropium Is Well Tolerated and Reduces Risk of Severe Exacerbations in COPD Patients.

被引：0
|
作者：
Welte, T.
Hartman, L. [1 ]
Polanowski, T. [1 ]
Hernandez, P.
机构：
[1] AZ, Lund, Sweden
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6188
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Fewer Severe Exacerbations in Patients with Mild to Moderate Asthma Treated with As-Needed Budesonide Plus Formoterol Compared with Maintenance Budesonide
    Barry, Henry C.
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (05) : 310 - 310
  • [32] Budesonide/formoterol vs formoterol, both via Turbuhaler®, in patients with moderate to severe COPD: Phase III study results
    Ichinose, Masakazu
    Samoro, Ronnie
    Fassakhov, Rustem
    Oguri, Mitsuru
    Ekelund, Jan
    Carlsson, Lars-Goran
    Fukuchi, Yoshinosuke
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [33] Glycopyrronium Is Safe And Well Tolerated In Patients With Moderate-To-Severe COPD
    Kerwin, E. M.
    D'Urzo, A. D.
    Overend, T.
    Goyal, P.
    Chen, H.
    Banerji, D.
    McBryan, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [34] Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD®
    Vogelmeier, Claus F.
    Asijee, Guus M.
    Kupas, Katrin
    Beeh, Kai M.
    ADVANCES IN THERAPY, 2015, 32 (06) : 537 - 547
  • [35] Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD®
    Claus F. Vogelmeier
    Guus M. Asijee
    Katrin Kupas
    Kai M. Beeh
    Advances in Therapy, 2015, 32 : 537 - 547
  • [36] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Exacerbations in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
    Rennard, S. I.
    Tashkin, D. P.
    Martin, P.
    Goldman, M.
    Martin, U. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [37] Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial
    Patel, Mitesh
    Pilcher, Janine
    Pritchard, Alison
    Perrin, Kyle
    Travers, Justin
    Shaw, Dominick
    Holt, Shaun
    Harwood, Matire
    Black, Peter
    Weatherall, Mark
    Beasley, Richard
    LANCET RESPIRATORY MEDICINE, 2013, 1 (01): : 32 - 42
  • [38] Effect of budesonide formoterol combined with tiotropium bromide on pulmonary function and inflammatory factors in patients with asthma-COPD overlap syndrome
    Jiang, Ting
    Li, Pengfei
    Wang, Yang
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2023, 51 (04) : 131 - 138
  • [39] Once-Daily Qva149 Improves Dyspnea, Quality Of Life And Reduces The Rate Of Exacerbations Compared To Tiotropium Plus Formoterol In COPD Patients: The Quantify Study
    Korn, S.
    Gebner, C.
    Schurmann, W.
    Forster, K.
    Sieder, C.
    Hiltl, S.
    Buhl, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [40] A novel oral treatment to reduce the risk of COPD exacerbations in patients with severe COPD
    不详
    FORMULARY, 2011, 46 (05) : 155 - 156
12345